Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs May 6, 2024
1847 Re-Engages ShareIntel to Investigate Potentially Improper and Illegal Trading Activity in the Company’s Common Stock May 6, 2024